Thanks, Outlander2 and Specyray, I don’t like to be overly bias...

Thanks, Outlander2 and Specyray,

I don’t like to be overly bias in my posts to allow people to form their own views. But that was my thoughts too, that the NextHerizon trial must be going well and the odds are any data drop will be good news. It should really just be a matter of how good.

Under continue disclosure rules, any major bad news and the trial would have been discontinued and we would have known. Any medico news such as Hervaxx was having a negligible effect they would not be pushing ahead with the neoHerizon study and or they would not be so keen to release a poster on the study only 5 months in. If, however there were early encouraging signs (and encouraging seem to be a word they use a lot). Its not possible to discuss that detail publicly without a formal price sensitive announcement as per ASX rules. So, what better way to do it then to compile a poster with the initial data. Announce it to the ASX one morning and let the data speak for itself.

Fingers and Toes crossed

General disclaimer: The above is my opinion only and may prove to be incorrect. Please do your own research or seek financial advice before making investment decisions. Investing in shares is inherently risky and could result in losing some or all of your capital invested.